RUTHERFORD, N.J., March 20, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”), an emerging leader in DNA-based diagnostics, announced today that Kamineni Hospitals based in Hyderabad, India, have introduced CGI’s FHACT™ diagnostic test for the detection and management of cervical cancer. This is the first broad-scale adoption of the genomic test in India where cervical cancer is the most prevalent cancer affecting women.
Help employers find you! Check out all the jobs and post your resume.
